Leidos Stock Forecast, Price & News

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Leidos in the last twelve months. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Leidos stock.
View analyst ratings for Leidos or view top-rated stocks.

Wall Street analysts have given Leidos a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Leidos wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Leidos is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Leidos.

Leidos Holdings, Inc. (NYSE:LDOS) issued its quarterly earnings data on Tuesday, May, 4th. The aerospace company reported $1.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.48 by $0.25. The aerospace company earned $3.32 billion during the quarter, compared to the consensus estimate of $3.25 billion. Leidos had a trailing twelve-month return on equity of 24.30% and a net margin of 5.64%. Leidos's revenue was up 14.9% compared to the same quarter last year. During the same period last year, the company posted $1.19 earnings per share.
View Leidos' earnings history.

Leidos' stock was trading at $97.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LDOS shares have increased by 5.6% and is now trading at $103.44.
View which stocks have been most impacted by COVID-19.

Leidos announced a quarterly dividend on Friday, April 30th. Shareholders of record on Tuesday, June 15th will be given a dividend of $0.34 per share on Wednesday, June 30th. This represents a $1.36 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend is Monday, June 14th.
View Leidos' dividend history.

Leidos pays an annual dividend of $1.36 per share and currently has a dividend yield of 1.28%. Leidos does not yet have a strong track record of dividend growth. The dividend payout ratio of Leidos is 23.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Leidos will have a dividend payout ratio of 18.81% next year. This indicates that Leidos will be able to sustain or increase its dividend.
View Leidos' dividend history.

Leidos updated its FY 2021 earnings guidance on Tuesday, May, 18th. The company provided earnings per share guidance of 6.350-6.650 for the period, compared to the Thomson Reuters consensus estimate of $6.380. The company issued revenue guidance of $13.70 billion-$14.10 billion, compared to the consensus revenue estimate of $13.88 billion.

10 brokers have issued 12-month price objectives for Leidos' stock. Their forecasts range from $109.00 to $125.00. On average, they expect Leidos' stock price to reach $116.38 in the next year. This suggests a possible upside of 12.5% from the stock's current price.
View analysts' price targets for Leidos or view top-rated stocks among Wall Street analysts.

636 employees have rated Leidos CEO Roger A. Krone on Glassdoor.com. Roger A. Krone has an approval rating of 85% among Leidos' employees.

Some companies that are related to Leidos include Accenture (ACN), International Business Machines (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Gartner (IT), Booz Allen Hamilton (BAH), Amdocs (DOX), CACI International (CACI), Teradata (TDC), ManTech International (MANT), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and ServiceSource International (SREV).
View all of LDOS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Leidos investors own include NVIDIA (NVDA), Lockheed Martin (LMT), The Boeing (BA), AbbVie (ABBV), Johnson & Johnson (JNJ), The Walt Disney (DIS), AT&T (T), Alibaba Group (BABA), CVS Health (CVS) and Intel (INTC).

Leidos trades on the New York Stock Exchange (NYSE) under the ticker symbol "LDOS."

Leidos' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include JPMorgan Chase & Co. (9.88%), BlackRock Inc. (7.27%), Price T Rowe Associates Inc. MD (2.80%), Boston Partners (1.77%), Victory Capital Management Inc. (1.62%) and Geode Capital Management LLC (1.56%). Company insiders that own Leidos stock include David G Fubini, Gary Stephen May, Jonathan W Scholl, Miriam E John and Roy E Stevens.
View institutional ownership trends for Leidos.

LDOS stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, National Pension Service, AQR Capital Management LLC, Glenmede Trust Co. NA, D. E. Shaw & Co. Inc., Ensign Peak Advisors Inc, Principal Financial Group Inc., and Principal Financial Group Inc.. Company insiders that have sold Leidos company stock in the last year include David G Fubini, Gary Stephen May, and Miriam E John.
View insider buying and selling activity for Leidos or view top insider-selling stocks.

LDOS stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Price T Rowe Associates Inc. MD, Millennium Management LLC, NFJ Investment Group LLC, Boston Partners, Schroder Investment Management Group, Howard Capital Management Group LLC, and Dudley & Shanley Inc..
View insider buying and selling activity for Leidos or or view top insider-buying stocks.

Shares of LDOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LDOS stock can currently be purchased for approximately $103.44.

Leidos has a market capitalization of $14.63 billion and generates $12.30 billion in revenue each year. The aerospace company earns $628 million in net income (profit) each year or $5.83 on an earnings per share basis.

Leidos employs 39,000 workers across the globe.

The following companies are subsidiares of Leidos: BECHTEL SAIC COMPANY LLC, Benham Military Communities LLC, Benham/Ellerbe Becket LLC, Dynetics, IMX Medical Management Services Inc, Leidos Arabia Company Limited, Leidos Biomedical Research Inc., Leidos CDM Solutions LLC, Leidos Consulting Engineers Inc., Leidos Cyber Inc., Leidos Engineering LLC, Leidos Europe Limited, Leidos Federal Healthcare Inc., Leidos Global Technology Corporation, Leidos Government Services Inc., Leidos Health Holdings LLC, Leidos Health LLC, Leidos Inc., Leidos Innovations Australia Pty Ltd., Leidos Innovations Corporation, Leidos Innovations Global Inc., Leidos Integrated Technology LLC, Leidos Intermediate Holdings Inc., Leidos Management Systems Designers Inc., Leidos Services Inc., Leidos Supply Limited, Mission Support Alliance LLC, QTC Holdings Inc., QTC Management Inc., QTC Medical Services Inc., Reveal Imaging Technologies Inc., Systems Made Simple Inc., Sytex Inc., The Sytex Group Inc., Varec Holdings Inc., and Varec Inc..

Leidos was founded in 1969.

The official website for Leidos is www.leidos.com.

Leidos is headquartered at 1750 PRESIDENTS STREET, RESTON VA, 20190.

Leidos' mailing address is 1750 PRESIDENTS STREET, RESTON VA, 20190. The aerospace company can be reached via phone at 571-526-6000 or via email at [email protected]